Benitec Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	20	7	9	33	10	10	20	14	7
Market Cap Growth	-	-29.60%	-71.60%	228.38%	5.62%	-52.85%	50.60%	84.49%	-
Enterprise Value	7	5	6	14	1	-6	9	1	-5
PE Ratio	-0.38	-0.34	-0.52	-2.40	-1.23	3.69	-2.52	-3.42	-0.42
PS Ratio	335.74	88.98	129.85	565.78	99.66	0.79	6.56	1.79	2.60
PB Ratio	2.04	33.04	3.29	1.67	0.99	0.58	1.56	0.90	0.56
P/FCF Ratio	-0.46	-0.37	-0.60	-2.56	-1.33	2.19	-2.97	-2.29	-0.51
P/OCF Ratio	-0.46	-0.37	-0.60	-2.60	-1.35	2.01	-2.99	-2.34	-0.52
EV/Sales Ratio	122.70	62.90	84.78	233.92	7.46	-0.50	2.93	0.18	-1.90
EV/EBITDA Ratio	0.54	-0.25	-0.35	-1.03	-0.10	-2.21	-1.12	-0.35	0.31
EV/EBIT Ratio	0.54	-0.24	-0.34	-0.99	-0.09	-2.34	-1.12	-0.35	0.31
EV/FCF Ratio	0.65	-0.26	-0.39	-1.06	-0.10	-1.39	-1.32	-0.23	0.38
Debt / Equity Ratio	0.03	2.77	0.28	0.01	0.04	-	-	-	-
Debt / EBITDA Ratio	-0.02	-0.03	-0.05	-0.02	-0.05	-	-	-	-
Debt / FCF Ratio	-0.02	-0.03	-0.05	-0.02	-0.05	-	-	-	-
Quick Ratio	3.56	0.65	1.62	14.48	8.69	6.92	8.04	19.45	18.58
Current Ratio	3.62	0.94	1.90	15.05	9.52	7.10	8.20	19.70	18.73
Asset Turnover	0.00	0.01	0.01	0.00	0.01	0.72	0.20	0.51	0.18
Interest Coverage	-806.78	-591.79	-568.00	-2312.67	-	-	-	-	-
Return on Equity (ROE)	-204.30%	-274.30%	-198.40%	-104.20%	-61.70%	17.60%	-57.80%	-28.20%	-116.00%
Return on Assets (ROA)	-142.80%	-183.20%	-152.10%	-93.70%	-53.70%	15.30%	-52.90%	-26.70%	-109.10%
Return on Capital (ROIC)	-136.49%	-2507.36%	-483.46%	-67.23%	-77.81%	15.57%	-62.94%	-26.40%	-129.34%
Earnings Yield	-106.49%	-293.13%	-192.08%	-41.59%	-81.39%	27.11%	-39.75%	-29.26%	-235.07%
FCF Yield	-57.35%	-269.92%	-167.86%	-39.10%	-75.05%	45.61%	-33.72%	-43.58%	-194.96%
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	0.00%	0.00%
Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.40%	0.00%	0.00%
Buyback Yield / Dilution	-58.91%	-188.30%	-90.24%	-320.63%	-19.19%	16.47%	-40.00%	-26.45%	-
Total Shareholder Return	-58.91%	-188.30%	-90.24%	-320.63%	-19.19%	16.47%	-39.90%	-26.45%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).